Affluent Medical (France) Top Management

AFME Stock   1.60  0.02  1.27%   
Affluent Medical employs about 49 people. The company is managed by 5 executives with a total tenure of roughly 115 years, averaging almost 23.0 years of service per executive, having 9.8 employees per reported executive. Analysis of Affluent Medical's management performance can provide insight into the company performance.
Michel Finance  Chairman
CEO Chairman
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affluent Medical SAS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Affluent Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.1162) % which means that it has lost $0.1162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3551) %, meaning that it generated substantial loss on money invested by shareholders. Affluent Medical's management efficiency ratios could be used to measure how well Affluent Medical manages its routine affairs as well as how well it operates its assets and liabilities.

Affluent Medical Workforce Comparison

Affluent Medical SAS is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is presently estimated at about 82.0. Affluent Medical totals roughly 49.0 in number of employees claiming about 60% of all equities under Medical Devices industry.

Affluent Medical SAS Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Affluent Medical SAS Price Series Summation is a cross summation of Affluent Medical price series and its benchmark/peer.

Affluent Medical Notable Stakeholders

An Affluent Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Affluent Medical often face trade-offs trying to please all of them. Affluent Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Affluent Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michel FinanceCEO ChairmanProfile
Pr MDMedical DirectorProfile
Sebastien LadetChief OfficerProfile
Olivier PierronDeputy OfficerProfile
Jerome GeoffroyChief OfficerProfile

About Affluent Medical Management Performance

The success or failure of an entity such as Affluent Medical SAS often depends on how effective the management is. Affluent Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Affluent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Affluent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of Affluent Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Affluent Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Affluent Medical's management manipulating its earnings.

Affluent Medical Workforce Analysis

Traditionally, organizations such as Affluent Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Affluent Medical within its industry.

Affluent Medical Manpower Efficiency

Return on Affluent Medical Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee302.4K
Net Loss Per Executive3M

Complementary Tools for Affluent Stock analysis

When running Affluent Medical's price analysis, check to measure Affluent Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affluent Medical is operating at the current time. Most of Affluent Medical's value examination focuses on studying past and present price action to predict the probability of Affluent Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affluent Medical's price. Additionally, you may evaluate how the addition of Affluent Medical to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data